{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:09:02Z","timestamp":1793815742806,"version":"4.6.1"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T00:00:00Z","timestamp":1656288000000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1A2B3002227"],"award-info":[{"award-number":["2017R1A2B3002227"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2020R1A5A2017323"],"award-info":[{"award-number":["2020R1A5A2017323"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer creates a complex tumor microenvironment (TME) composed of immune cells, stromal cells, blood vessels, and various other cellular and extracellular elements. It is essential for the development of anti-cancer combination therapies to understand and overcome this high heterogeneity and complexity as well as the dynamic interactions between them within the TME. Recent treatment strategies incorporating immune-checkpoint inhibitors and anti-angiogenic agents have brought many changes and advances in clinical cancer treatment. However, there are still challenges for immune suppressive tumors, which are characterized by a lack of T cell infiltration and treatment resistance. In this review, we will investigate the crosstalk between immunity and angiogenesis in the TME. In addition, we will look at strategies designed to enhance anti-cancer immunity, to convert \u201cimmune suppressive tumors\u201d into \u201cimmune activating tumors,\u201d and the mechanisms by which these strategies enhance effector immune cell infiltration.<\/jats:p>","DOI":"10.1007\/s12272-022-01389-z","type":"journal-article","created":{"date-parts":[[2022,6,27]],"date-time":"2022-06-27T04:02:42Z","timestamp":1656302562000},"page":"401-416","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Crosstalk between angiogenesis and immune regulation in the tumor microenvironment"],"prefix":"10.1007","volume":"45","author":[{"given":"Hei Jung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Rae","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5756-7169","authenticated-orcid":false,"given":"You Mie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,27]]},"reference":[{"key":"1389_CR1","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1111\/imm.12941","volume":"154","author":"T Ahrends","year":"2018","unstructured":"Ahrends T, Borst J (2018) The opposing roles of CD4(+) T cells in anti-tumour immunity. Immunology 154:582\u2013592. https:\/\/doi.org\/10.1111\/imm.12941","journal-title":"Immunology"},{"key":"1389_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3389\/fimmu.2018.00527","volume":"9","author":"A Albini","year":"2018","unstructured":"Albini A, Bruno A, Noonan DM, Mortara L (2018) Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: implications for immunotherapy. Front Immunol 9:527. https:\/\/doi.org\/10.3389\/fimmu.2018.00527","journal-title":"Front Immunol"},{"key":"1389_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.4049\/jimmunol.1701693","volume":"200","author":"S Amigorena","year":"2018","unstructured":"Amigorena S (2018) Dendritic cells on the way to glory. J Immunol 200:885\u2013886. https:\/\/doi.org\/10.4049\/jimmunol.1701693","journal-title":"J Immunol"},{"key":"1389_CR4","doi-asserted-by":"publisher","first-page":"1720827","DOI":"10.1155\/2016\/1720827","volume":"2016","author":"A Arce-Sillas","year":"2016","unstructured":"Arce-Sillas A, \u00c3lvarez-Luqu\u00edn DD, Tamaya-Dom\u00ednguez B, Gomez-Fuentes S, Trejo-Garc\u00eda A, Melo-Salas M, C\u00e1rdenas G, Rodr\u00edguez-Ram\u00edrez J, Adalid-Peralta L (2016) Regulatory T cells: molecular actions on effector cells in immune regulation. J Immunol Res 2016:1720827. https:\/\/doi.org\/10.1155\/2016\/1720827","journal-title":"J Immunol Res"},{"key":"1389_CR5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.imbio.2017.11.001","volume":"223","author":"S Arora","year":"2018","unstructured":"Arora S, Dev K, Agarwal B, Das P, Syed MA (2018) Macrophages: their role, activation and polarization in pulmonary diseases. Immunobiology 223:383\u2013396. https:\/\/doi.org\/10.1016\/j.imbio.2017.11.001","journal-title":"Immunobiology"},{"key":"1389_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1084\/jem.20051395","volume":"202","author":"C Asselin-Paturel","year":"2005","unstructured":"Asselin-Paturel C, Trinchieri G (2005) Production of type I interferons: plasmacytoid dendritic cells and beyond. J Exp Med 202:461\u2013465. https:\/\/doi.org\/10.1084\/jem.20051395","journal-title":"J Exp Med"},{"key":"1389_CR7","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","volume":"18","author":"J Banchereau","year":"2000","unstructured":"Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767\u2013811. https:\/\/doi.org\/10.1146\/annurev.immunol.18.1.767","journal-title":"Annu Rev Immunol"},{"key":"1389_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s00262-016-1849-y","volume":"65","author":"M Baniyash","year":"2016","unstructured":"Baniyash M (2016) Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy. Cancer Immunol Immunother 65:857\u2013867. https:\/\/doi.org\/10.1007\/s00262-016-1849-y","journal-title":"Cancer Immunol Immunother"},{"key":"1389_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00909","author":"AD Barrow","year":"2019","unstructured":"Barrow AD, Martin CJ, Colonna M (2019) The natural cytotoxicity receptors in health and disease. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.00909","journal-title":"Front Immunol"},{"key":"1389_CR10","doi-asserted-by":"publisher","first-page":"5373","DOI":"10.1200\/jco.2006.05.9584","volume":"24","author":"GJ Bates","year":"2006","unstructured":"Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL, Banham AH (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24:5373\u20135380. https:\/\/doi.org\/10.1200\/jco.2006.05.9584","journal-title":"J Clin Oncol"},{"key":"1389_CR11","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1172\/jci66375","volume":"124","author":"CA Bauer","year":"2014","unstructured":"Bauer CA, Kim EY, Marangoni F, Carrizosa E, Claudio NM, Mempel TR (2014) Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction. J Clin Investig 124:2425\u20132440. https:\/\/doi.org\/10.1172\/jci66375","journal-title":"J Clin Investig"},{"key":"1389_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","volume":"27","author":"CL Bennett","year":"2001","unstructured":"Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20\u201321. https:\/\/doi.org\/10.1038\/83713","journal-title":"Nat Genet"},{"key":"1389_CR13","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.coi.2006.05.011","volume":"18","author":"R Bonasio","year":"2006","unstructured":"Bonasio R, Von Andrian UH (2006) Generation, migration and function of circulating dendritic cells. Curr Opin Immunol 18:503\u2013511. https:\/\/doi.org\/10.1016\/j.coi.2006.05.011","journal-title":"Curr Opin Immunol"},{"key":"1389_CR14","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP B\u00f6ttcher","year":"2018","unstructured":"B\u00f6ttcher JP, Bonavita E, Chakravarty P, Blees H, Cabeza-Cabrerizo M, Sammicheli S, Rogers NC, Sahai E, Zelenay S, Sousa REC (2018) NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell 172:1022-1037.e1014. https:\/\/doi.org\/10.1016\/j.cell.2018.01.004","journal-title":"Cell"},{"key":"1389_CR15","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.4049\/jimmunol.177.3.1460","volume":"177","author":"S Bourbi\u00e9-Vaudaine","year":"2006","unstructured":"Bourbi\u00e9-Vaudaine S, Blanchard N, Hivroz C, Rom\u00e9o PH (2006) Dendritic cells can turn CD4+ T lymphocytes into vascular endothelial growth factor-carrying cells by intercellular neuropilin-1 transfer. J Immunol 177:1460\u20131469. https:\/\/doi.org\/10.4049\/jimmunol.177.3.1460","journal-title":"J Immunol"},{"key":"1389_CR16","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1126\/science.1072615","volume":"297","author":"C Bourgeois","year":"2002","unstructured":"Bourgeois C, Rocha B, Tanchot C (2002) A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory. Science 297:2060\u20132063. https:\/\/doi.org\/10.1126\/science.1072615","journal-title":"Science"},{"key":"1389_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3389\/fonc.2014.00131","volume":"4","author":"A Bruno","year":"2014","unstructured":"Bruno A, Pagani A, Pulze L, Albini A, Dallaglio K, Noonan DM, Mortara L (2014) Orchestration of angiogenesis by immune cells. Front Oncol 4:131. https:\/\/doi.org\/10.3389\/fonc.2014.00131","journal-title":"Front Oncol"},{"key":"1389_CR18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.lungcan.2015.09.023","volume":"90","author":"I Canadas","year":"2015","unstructured":"Canadas I, Taus A, Villanueva X, Arpi O, Pijuan L, Rodriguez Y, Menendez S, Mojal S, Rojo F, Albanell J, Rovira A, Arriola E (2015) Angiopoietin-2 is a negative prognostic marker in small cell lung cancer. Lung Cancer 90:302\u2013306. https:\/\/doi.org\/10.1016\/j.lungcan.2015.09.023","journal-title":"Lung Cancer"},{"key":"1389_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","volume":"407","author":"P Carmeliet","year":"2000","unstructured":"Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249\u2013257. https:\/\/doi.org\/10.1038\/35025220","journal-title":"Nature"},{"key":"1389_CR20","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1158\/1078-0432.CCR-09-3073","volume":"16","author":"SS Chae","year":"2010","unstructured":"Chae SS, Kamoun WS, Farrar CT, Kirkpatrick ND, Niemeyer E, De Graaf AM, Sorensen AG, Munn LL, Jain RK, Fukumura D (2010) Angiopoietin-2 interferes with anti-VEGFR2-induced vessel normalization and survival benefit in mice bearing gliomas. Clin Cancer Res 16:3618\u20133627. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-3073","journal-title":"Clin Cancer Res"},{"key":"1389_CR21","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","volume":"76","author":"AL Chang","year":"2016","unstructured":"Chang AL, Miska J, Wainwright DA, Dey M, Rivetta CV, Yu D, Kanojia D, Pituch KC, Qiao J, Pytel P, Han Y, Wu M, Zhang L, Horbinski CM, Ahmed AU, Lesniak MS (2016) CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells. Cancer Res 76:5671\u20135682. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0144","journal-title":"Cancer Res"},{"key":"1389_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","volume":"39","author":"DS Chen","year":"2013","unstructured":"Chen DS, Mellman I (2013) Oncology meets immunology: the cancer-immunity cycle. Immunity 39:1\u201310. https:\/\/doi.org\/10.1016\/j.immuni.2013.07.012","journal-title":"Immunity"},{"key":"1389_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-407704-1.00001-4","volume":"301","author":"P Chen","year":"2013","unstructured":"Chen P, Bonaldo P (2013) Role of macrophage polarization in tumor angiogenesis and vessel normalization: implications for new anticancer therapies. Int Rev Cell Mol Biol 301:1\u201335. https:\/\/doi.org\/10.1016\/B978-0-12-407704-1.00001-4","journal-title":"Int Rev Cell Mol Biol"},{"key":"1389_CR24","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1073\/pnas.052676899","volume":"99","author":"LE Cheng","year":"2002","unstructured":"Cheng LE, Ohl\u00e9n C, Nelson BH, Greenberg PD (2002) Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death. Proc Natl Acad Sci USA 99:3001\u20133006. https:\/\/doi.org\/10.1073\/pnas.052676899","journal-title":"Proc Natl Acad Sci USA"},{"key":"1389_CR25","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.4049\/jimmunol.1002802","volume":"186","author":"SB Coffelt","year":"2011","unstructured":"Coffelt SB, Chen YY, Muthana M, Welford AF, Tal AO, Scholz A, Plate KH, Reiss Y, Murdoch C, De Palma M, Lewis CE (2011) Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion. J Immunol 186:4183\u20134190. https:\/\/doi.org\/10.4049\/jimmunol.1002802","journal-title":"J Immunol"},{"key":"1389_CR26","first-page":"315","volume":"37","author":"P Conti","year":"2007","unstructured":"Conti P, Castellani ML, Kempuraj D, Salini V, Vecchiet J, Tete S, Mastrangelo F, Perrella A, De Lutiis MA, Tagen M, Theoharides TC (2007) Role of mast cells in tumor growth. Ann Clin Lab Sci 37:315\u2013322","journal-title":"Ann Clin Lab Sci"},{"key":"1389_CR27","doi-asserted-by":"publisher","first-page":"5535","DOI":"10.1158\/0008-5472.CAN-04-1272","volume":"64","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Cheng P, Mottram P, Alvarez X, Moons L, Evdemon-Hogan M, Wei S, Zou L, Kryczek I, Hoyle G, Lackner A, Carmeliet P, Zou W (2004a) Dendritic cell subsets differentially regulate angiogenesis in human ovarian cancer. Cancer Res 64:5535\u20135538. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1272","journal-title":"Cancer Res"},{"key":"1389_CR28","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004b) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942\u2013949. https:\/\/doi.org\/10.1038\/nm1093","journal-title":"Nat Med"},{"key":"1389_CR29","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-3-030-49270-0_6","volume-title":"Tumor microenvironment: hematopoietic cells\u2014Part B","author":"RE Dadey","year":"2020","unstructured":"Dadey RE, Workman CJ, Vignali DAA (2020) Regulatory T cells in the tumor microenvironment. In: Birbrair A (ed) Tumor microenvironment: hematopoietic cells\u2014Part B. Springer, Cham, pp 105\u2013134.\u00a0https:\/\/doi.org\/10.1007\/978-3-030-49270-0_6"},{"key":"1389_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/imm.12917","volume":"154","author":"S Damgaci","year":"2018","unstructured":"Damgaci S, Ibrahim-Hashim A, Enriquez-Navas PM, Pilon-Thomas S, Guvenis A, Gillies RJ (2018) Hypoxia and acidosis: immune suppressors and therapeutic targets. Immunology 154:354\u2013362. https:\/\/doi.org\/10.1111\/imm.12917","journal-title":"Immunology"},{"key":"1389_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2020.104076","volume":"352","author":"S Dasgupta","year":"2020","unstructured":"Dasgupta S, Dasgupta S, Bandyopadhyay M (2020) Regulatory B cells in infection, inflammation, and autoimmunity. Cell Immunol 352:104076. https:\/\/doi.org\/10.1016\/j.cellimm.2020.104076","journal-title":"Cell Immunol"},{"key":"1389_CR32","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2020.07.004","volume":"38","author":"M De Miguel","year":"2020","unstructured":"De Miguel M, Calvo E (2020) Clinical challenges of immune checkpoint inhibitors. Cancer Cell 38:326\u2013333. https:\/\/doi.org\/10.1016\/j.ccell.2020.07.004","journal-title":"Cancer Cell"},{"key":"1389_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ccell.2017.11.019","volume":"33","author":"P\u00c3 De Mingo","year":"2018","unstructured":"De Mingo P\u00c3, Gardner A, Hiebler S, Soliman H, Rugo HS, Krummel MF, Coussens LM, Ruffell B (2018) TIM-3 regulates CD103(+) dendritic cell function and response to chemotherapy in breast cancer. Cancer Cell 33:60-74.e66. https:\/\/doi.org\/10.1016\/j.ccell.2017.11.019","journal-title":"Cancer Cell"},{"key":"1389_CR34","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc.2017.51","volume":"17","author":"M De Palma","year":"2017","unstructured":"De Palma M, Biziato D, Petrova TV (2017) Microenvironmental regulation of tumour angiogenesis. Nat Rev Cancer 17:457\u2013474. https:\/\/doi.org\/10.1038\/nrc.2017.51","journal-title":"Nat Rev Cancer"},{"key":"1389_CR35","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","volume":"8","author":"M De Palma","year":"2005","unstructured":"De Palma M, Venneri MA, Galli R, Sergi Sergi L, Politi LS, Sampaolesi M, Naldini L (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8:211\u2013226. https:\/\/doi.org\/10.1016\/j.ccr.2005.08.002","journal-title":"Cancer Cell"},{"key":"1389_CR36","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.1200\/JCO.2009.27.2146","volume":"28","author":"ML Disis","year":"2010","unstructured":"Disis ML (2010) Immune regulation of cancer. J Clin Oncol 28:4531\u20134538. https:\/\/doi.org\/10.1200\/JCO.2009.27.2146","journal-title":"J Clin Oncol"},{"key":"1389_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/eji.200939903","volume":"40","author":"L Dolcetti","year":"2010","unstructured":"Dolcetti L, Peranzoni E, Ugel S, Marigo I, Fernandez Gomez A, Mesa C, Geilich M, Winkels G, Traggiai E, Casati A, Grassi F, Bronte V (2010) Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur J Immunol 40:22\u201335. https:\/\/doi.org\/10.1002\/eji.200939903","journal-title":"Eur J Immunol"},{"key":"1389_CR38","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fimmu.2013.00438","volume":"4","author":"AM Dudek","year":"2013","unstructured":"Dudek AM, Martin S, Garg AD, Agostinis P (2013) Immature, semi-mature, and fully mature dendritic cells: toward a DC-cancer cells interface that augments anticancer immunity. Front Immunol 4:438. https:\/\/doi.org\/10.3389\/fimmu.2013.00438","journal-title":"Front Immunol"},{"key":"1389_CR39","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.4049\/jimmunol.0802317","volume":"182","author":"ME El Shikh","year":"2009","unstructured":"El Shikh ME, El Sayed RM, Szakal AK, Tew JG (2009) T-independent antibody responses to T-dependent antigens: a novel follicular dendritic cell-dependent activity. J Immunol 182:3482\u20133491. https:\/\/doi.org\/10.4049\/jimmunol.0802317","journal-title":"J Immunol"},{"key":"1389_CR40","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1158\/0008-5472.Can-11-3687","volume":"72","author":"A Facciabene","year":"2012","unstructured":"Facciabene A, Motz GT, Coukos G (2012) T-regulatory cells: key players in tumor immune escape and angiogenesis. Cancer Res 72:2162\u20132171. https:\/\/doi.org\/10.1158\/0008-5472.Can-11-3687","journal-title":"Cancer Res"},{"key":"1389_CR41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10169","volume":"475","author":"A Facciabene","year":"2011","unstructured":"Facciabene A, Peng X, Hagemann IS, Balint K, Barchetti A, Wang LP, Gimotty PA, Gilks CB, Lal P, Zhang L, Coukos G (2011) Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells. Nature 475:226\u2013230. https:\/\/doi.org\/10.1038\/nature10169","journal-title":"Nature"},{"key":"1389_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.canlet.2012.08.018","volume":"328","author":"E Fagiani","year":"2013","unstructured":"Fagiani E, Christofori G (2013) Angiopoietins in angiogenesis. Cancer Lett 328:18\u201326. https:\/\/doi.org\/10.1016\/j.canlet.2012.08.018","journal-title":"Cancer Lett"},{"key":"1389_CR43","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13045-018-0637-x","volume":"11","author":"P Fang","year":"2018","unstructured":"Fang P, Li X, Dai J, Cole L, Camacho JA, Zhang Y, Ji Y, Wang J, Yang XF, Wang H (2018) Immune cell subset differentiation and tissue inflammation. J Hematol Oncol 11:97. https:\/\/doi.org\/10.1186\/s13045-018-0637-x","journal-title":"J Hematol Oncol"},{"key":"1389_CR44","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234","author":"B Farhood","year":"2019","unstructured":"Farhood B, Najafi M, Mortezaee K (2019) CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol 234:8509\u20138521. https:\/\/doi.org\/10.1002\/jcp.27782","journal-title":"J Cell Physiol"},{"key":"1389_CR45","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/ni904","volume":"4","author":"JD Fontenot","year":"2003","unstructured":"Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4:330\u2013336. https:\/\/doi.org\/10.1038\/ni904","journal-title":"Nat Immunol"},{"key":"1389_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jbspin.2012.08.013","volume":"80","author":"L Frenzel","year":"2013","unstructured":"Frenzel L, Hermine O (2013) Mast cells and inflammation. Jt Bone Spine 80:141\u2013145. https:\/\/doi.org\/10.1016\/j.jbspin.2012.08.013","journal-title":"Jt Bone Spine"},{"key":"1389_CR47","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1158\/0008-5472.CAN-10-3055","volume":"71","author":"M Fujita","year":"2011","unstructured":"Fujita M, Kohanbash G, Fellows-Mayle W, Hamilton RL, Komohara Y, Decker SA, Ohlfest JR, Okada H (2011) COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Res 71:2664\u20132674. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3055","journal-title":"Cancer Res"},{"key":"1389_CR48","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura D, Kloepper J, Amoozgar Z, Duda DG, Jain RK (2018) Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol 15:325\u2013340. https:\/\/doi.org\/10.1038\/nrclinonc.2018.29","journal-title":"Nat Rev Clin Oncol"},{"key":"1389_CR49","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1182\/blood.V92.11.4150","volume":"92","author":"D Gabrilovich","year":"1998","unstructured":"Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S, Carbone DP (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92:4150\u20134166.\u00a0https:\/\/doi.org\/10.1182\/blood.V92.11.4150","journal-title":"Blood"},{"key":"1389_CR50","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162\u2013174. https:\/\/doi.org\/10.1038\/nri2506","journal-title":"Nat Rev Immunol"},{"key":"1389_CR51","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nri3175","volume":"12","author":"DI Gabrilovich","year":"2012","unstructured":"Gabrilovich DI, Ostrand-Rosenberg S, Bronte V (2012) Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 12:253\u2013268. https:\/\/doi.org\/10.1038\/nri3175","journal-title":"Nat Rev Immunol"},{"key":"1389_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.585214","volume":"11","author":"X Gao","year":"2020","unstructured":"Gao X, Sui H, Zhao S, Gao X, Su Y, Qu P (2020) Immunotherapy targeting myeloid-derived suppressor cells (MDSCs) in tumor microenvironment. Front Immunol 11:585214. https:\/\/doi.org\/10.3389\/fimmu.2020.585214","journal-title":"Front Immunol"},{"key":"1389_CR53","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1158\/1078-0432.Ccr-04-0487","volume":"11","author":"W Gong","year":"2005","unstructured":"Gong W, Wang L, Yao JC, Ajani JA, Wei D, Aldape KD, Xie K, Sawaya R, Huang S (2005) Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer. Clin Cancer Res 11:1386\u20131393. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-04-0487","journal-title":"Clin Cancer Res"},{"key":"1389_CR54","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1182\/blood-2009-07-234872","volume":"116","author":"S Gregori","year":"2010","unstructured":"Gregori S, Tomasoni D, Pacciani V, Scirpoli M, Battaglia M, Magnani CF, Hauben E, Roncarolo MG (2010) Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4\/HLA-G pathway. Blood 116:935\u2013944. https:\/\/doi.org\/10.1182\/blood-2009-07-234872","journal-title":"Blood"},{"key":"1389_CR55","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41416-018-0333-1","volume":"120","author":"C Groth","year":"2019","unstructured":"Groth C, Hu X, Weber R, Fleming V, Altevogt P, Utikal J, Umansky V (2019) Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. Br J Cancer 120:16\u201325. https:\/\/doi.org\/10.1038\/s41416-018-0333-1","journal-title":"Br J Cancer"},{"key":"1389_CR56","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ni.3518","volume":"17","author":"C Guillerey","year":"2016","unstructured":"Guillerey C, Huntington ND, Smyth MJ (2016) Targeting natural killer cells in cancer immunotherapy. Nat Immunol 17:1025\u20131036. https:\/\/doi.org\/10.1038\/ni.3518","journal-title":"Nat Immunol"},{"key":"1389_CR57","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"1389_CR58","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","volume":"69","author":"M Hashimoto","year":"2018","unstructured":"Hashimoto M, Kamphorst AO, Im SJ, Kissick HT, Pillai RN, Ramalingam SS, Araki K, Ahmed R (2018) CD8 T cell exhaustion in chronic infection and cancer: opportunities for interventions. Annu Rev Med 69:301\u2013318. https:\/\/doi.org\/10.1146\/annurev-med-012017-043208","journal-title":"Annu Rev Med"},{"key":"1389_CR59","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1111\/j.1349-7006.2010.01614.x","volume":"101","author":"H Hasita","year":"2010","unstructured":"Hasita H, Komohara Y, Okabe H, Masuda T, Ohnishi K, Lei XF, Beppu T, Baba H, Takeya M (2010) Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma. Cancer Sci 101:1913\u20131919. https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01614.x","journal-title":"Cancer Sci"},{"key":"1389_CR60","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","volume":"577","author":"BA Helmink","year":"2020","unstructured":"Helmink BA, Reddy SM, Gao J, Zhang S, Basar R, Thakur R, Yizhak K, Sade-Feldman M, Blando J, Han G, Gopalakrishnan V, Xi Y, Zhao H, Amaria RN, Tawbi HA, Cogdill AP, Liu W, Lebleu VS, Kugeratski FG, Patel S, Davies MA, Hwu P, Lee JE, Gershenwald JE, Lucci A, Arora R, Woodman S, Keung EZ, Gaudreau PO, Reuben A, Spencer CN, Burton EM, Haydu LE, Lazar AJ, Zapassodi R, Hudgens CW, Ledesma DA, Ong S, Bailey M, Warren S, Rao D, Krijgsman O, Rozeman EA, Peeper D, Blank CU, Schumacher TN, Butterfield LH, Zelazowska MA, Mcbride KM, Kalluri R, Allison J, Petitprez F, Fridman WH, Saut\u00e8s-Fridman C, Hacohen N, Rezvani K, Sharma P, Tetzlaff MT, Wang L, Wargo JA (2020) B cells and tertiary lymphoid structures promote immunotherapy response. Nature 577:549\u2013555. https:\/\/doi.org\/10.1038\/s41586-019-1922-8","journal-title":"Nature"},{"key":"1389_CR61","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3389\/fimmu.2016.00621","volume":"7","author":"SA Hendry","year":"2016","unstructured":"Hendry SA, Farnsworth RH, Solomon B, Achen MG, Stacker SA, Fox SB (2016) The role of the tumor vasculature in the host immune response: implications for therapeutic strategies targeting the tumor microenvironment. Front Immunol 7:621. https:\/\/doi.org\/10.3389\/fimmu.2016.00621","journal-title":"Front Immunol"},{"key":"1389_CR62","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.4049\/jimmunol.1100889","volume":"187","author":"M Heusinkveld","year":"2011","unstructured":"Heusinkveld M, De Vos Van Steenwijk PJ, Goedemans R, Ramwadhdoebe TH, Gorter A, Welters MJ, Van Hall T, Van Der Burg SH (2011) M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells. J Immunol 187:1157\u20131165. https:\/\/doi.org\/10.4049\/jimmunol.1100889","journal-title":"J Immunol"},{"key":"1389_CR63","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1158\/1078-0432.Ccr-06-0369","volume":"12","author":"N Hiraoka","year":"2006","unstructured":"Hiraoka N, Onozato K, Kosuge T, Hirohashi S (2006) Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12:5423\u20135434. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-0369","journal-title":"Clin Cancer Res"},{"key":"1389_CR64","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057\u20131061. https:\/\/doi.org\/10.1126\/science.1079490","journal-title":"Science"},{"key":"1389_CR65","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","volume":"66","author":"B Huang","year":"2006","unstructured":"Huang B, Pan PY, Li Q, Sato AI, Levy DE, Bromberg J, Divino CM, Chen SH (2006) Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Res 66:1123\u20131131. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-1299","journal-title":"Cancer Res"},{"key":"1389_CR66","doi-asserted-by":"publisher","first-page":"2943","DOI":"10.1158\/0008-5472.CAN-12-4354","volume":"73","author":"Y Huang","year":"2013","unstructured":"Huang Y, Goel S, Duda DG, Fukumura D, Jain RK (2013) Vascular normalization as an emerging strategy to enhance cancer immunotherapy. Cancer Res 73:2943\u20132948. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-4354","journal-title":"Cancer Res"},{"key":"1389_CR67","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/s0891-5849(00)00223-9","volume":"28","author":"AK Hubbard","year":"2000","unstructured":"Hubbard AK, Rothlein R (2000) Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic Biol Med 28:1379\u20131386. https:\/\/doi.org\/10.1016\/s0891-5849(00)00223-9","journal-title":"Free Radic Biol Med"},{"key":"1389_CR68","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1158\/0008-5472.Can-14-3587","volume":"75","author":"R Hughes","year":"2015","unstructured":"Hughes R, Qian BZ, Rowan C, Muthana M, Keklikoglou I, Olson OC, Tazzyman S, Danson S, Addison C, Clemons M, Gonzalez-Angulo AM, Joyce JA, De Palma M, Pollard JW, Lewis CE (2015) Perivascular M2 macrophages stimulate tumor relapse after chemotherapy. Cancer Res 75:3479\u20133491. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-3587","journal-title":"Cancer Res"},{"key":"1389_CR69","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1084\/jem.20130783","volume":"210","author":"A Iannello","year":"2013","unstructured":"Iannello A, Thompson TW, Ardolino M, Lowe SW, Raulet DH (2013) p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. J Exp Med 210:2057\u20132069. https:\/\/doi.org\/10.1084\/jem.20130783","journal-title":"J Exp Med"},{"key":"1389_CR70","first-page":"4404","volume":"9","author":"F Ichihara","year":"2003","unstructured":"Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H (2003) Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 9:4404\u20134408","journal-title":"Clin Cancer Res"},{"key":"1389_CR71","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/sj.gt.3301703","volume":"9","author":"S Indraccolo","year":"2002","unstructured":"Indraccolo S, Gola E, Rosato A, Minuzzo S, Habeler W, Tisato V, Roni V, Esposito G, Morini M, Albini A, Noonan DM, Ferrantini M, Amadori A, Chieco-Bianchi L (2002) Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells. Gene Ther 9:867\u2013878. https:\/\/doi.org\/10.1038\/sj.gt.3301703","journal-title":"Gene Ther"},{"key":"1389_CR72","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/978-3-030-35723-8_4","volume-title":"Tumor microenvironment: hematopoietic cells\u2014Part A","author":"K Iwahori","year":"2020","unstructured":"Iwahori K (2020) Cytotoxic CD8+ lymphocytes in the tumor microenvironment. In: Birbrair A (ed) Tumor microenvironment: hematopoietic cells\u2014Part A. Springer, Cham, pp 53\u201362.\u00a0https:\/\/doi.org\/10.1007\/978-3-030-35723-8_4"},{"key":"1389_CR73","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/nm0901-987","volume":"7","author":"RK Jain","year":"2001","unstructured":"Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7:987\u2013989. https:\/\/doi.org\/10.1038\/nm0901-987","journal-title":"Nat Med"},{"key":"1389_CR74","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307:58\u201362. https:\/\/doi.org\/10.1126\/science.1104819","journal-title":"Science"},{"key":"1389_CR75","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","volume":"26","author":"RK Jain","year":"2014","unstructured":"Jain RK (2014) Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell 26:605\u2013622. https:\/\/doi.org\/10.1016\/j.ccell.2014.10.006","journal-title":"Cancer Cell"},{"key":"1389_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12272-020-01287-2","volume":"44","author":"JH Jeong","year":"2021","unstructured":"Jeong JH, Ojha U, Lee YM (2021) Pathological angiogenesis and inflammation in tissues. Arch Pharmacal Res 44:1\u201315. https:\/\/doi.org\/10.1007\/s12272-020-01287-2","journal-title":"Arch Pharmacal Res"},{"key":"1389_CR77","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","volume":"30","author":"SZ Josefowicz","year":"2012","unstructured":"Josefowicz SZ, Lu LF, Rudensky AY (2012) Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30:531\u2013564. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141623","journal-title":"Annu Rev Immunol"},{"key":"1389_CR78","doi-asserted-by":"publisher","first-page":"318","DOI":"10.4132\/jptm.2015.06.01","volume":"49","author":"KY Jung","year":"2015","unstructured":"Jung KY, Cho SW, Kim YA, Kim D, Oh BC, Park DJ, Park YJ (2015) Cancers with higher density of tumor-associated macrophages were associated with poor survival rates. J Pathol Transl Med 49:318\u2013324. https:\/\/doi.org\/10.4132\/jptm.2015.06.01","journal-title":"J Pathol Transl Med"},{"key":"1389_CR79","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1073\/pnas.1902145116","volume":"117","author":"AS Kashyap","year":"2020","unstructured":"Kashyap AS, Schmittnaegel M, Rigamonti N, Pais-Ferreira D, Mueller P, Buchi M, Ooi CH, Kreuzaler M, Hirschmann P, Guichard A, Rieder N, Bill R, Herting F, Kienast Y, Dirnhofer S, Klein C, Hoves S, Ries CH, Corse E, De Palma M, Zippelius A (2020) Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy. Proc Natl Acad Sci USA 117:541\u2013551. https:\/\/doi.org\/10.1073\/pnas.1902145116","journal-title":"Proc Natl Acad Sci USA"},{"key":"1389_CR80","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","volume":"34","author":"T Kawai","year":"2011","unstructured":"Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34:637\u2013650. https:\/\/doi.org\/10.1016\/j.immuni.2011.05.006","journal-title":"Immunity"},{"key":"1389_CR81","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ni909","volume":"4","author":"R Khattri","year":"2003","unstructured":"Khattri R, Cox T, Yasayko SA, Ramsdell F (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4:337\u2013342. https:\/\/doi.org\/10.1038\/ni909","journal-title":"Nat Immunol"},{"key":"1389_CR82","doi-asserted-by":"publisher","first-page":"R14","DOI":"10.1186\/bcr3098","volume":"14","author":"SJ Kim","year":"2012","unstructured":"Kim SJ, Shin JY, Lee KD, Bae YK, Sung KW, Nam SJ, Chun KH (2012) MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7. Breast Cancer Res 14:R14. https:\/\/doi.org\/10.1186\/bcr3098","journal-title":"Breast Cancer Res"},{"key":"1389_CR83","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/imcb.12236","volume":"97","author":"SY Kim","year":"2019","unstructured":"Kim SY, Nair MG (2019) Macrophages in wound healing: activation and plasticity. Immunol Cell Biol 97:258\u2013267. https:\/\/doi.org\/10.1111\/imcb.12236","journal-title":"Immunol Cell Biol"},{"key":"1389_CR84","first-page":"5522","volume":"56","author":"H Kimura","year":"1996","unstructured":"Kimura H, Braun RD, Ong ET, Hsu R, Secomb TW, Papahadjopoulos D, Hong K, Dewhirst MW (1996) Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 56:5522\u20135528","journal-title":"Cancer Res"},{"key":"1389_CR85","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s10637-010-9526-z","volume":"30","author":"HL Kindler","year":"2012","unstructured":"Kindler HL, Wroblewski K, Wallace JA, Hall MJ, Locker G, Nattam S, Agamah E, Stadler WM, Vokes EE (2012) Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium. Investig N Drugs 30:382\u2013386. https:\/\/doi.org\/10.1007\/s10637-010-9526-z","journal-title":"Investig N Drugs"},{"key":"1389_CR86","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/bjc.2017.401","volume":"118","author":"Y Kitano","year":"2018","unstructured":"Kitano Y, Okabe H, Yamashita YI, Nakagawa S, Saito Y, Umezaki N, Tsukamoto M, Yamao T, Yamamura K, Arima K, Kaida T, Miyata T, Mima K, Imai K, Hashimoto D, Komohara Y, Chikamoto A, Ishiko T, Baba H (2018) Tumour-infiltrating inflammatory and immune cells in patients with extrahepatic cholangiocarcinoma. Br J Cancer 118:171\u2013180. https:\/\/doi.org\/10.1038\/bjc.2017.401","journal-title":"Br J Cancer"},{"key":"1389_CR87","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1177\/1947601911423654","volume":"2","author":"BL Krock","year":"2011","unstructured":"Krock BL, Skuli N, Simon MC (2011) Hypoxia-induced angiogenesis: good and evil. Genes Cancer 2:1117\u20131133. https:\/\/doi.org\/10.1177\/1947601911423654","journal-title":"Genes Cancer"},{"key":"1389_CR88","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.it.2016.01.004","volume":"37","author":"V Kumar","year":"2016","unstructured":"Kumar V, Patel S, Tcyganov E, Gabrilovich DI (2016) The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends Immunol 37:208\u2013220. https:\/\/doi.org\/10.1016\/j.it.2016.01.004","journal-title":"Trends Immunol"},{"key":"1389_CR89","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3389\/fimmu.2020.00940","volume":"11","author":"A Labani-Motlagh","year":"2020","unstructured":"Labani-Motlagh A, Ashja-Mahdavi M, Loskog A (2020) The tumor microenvironment: a milieu hindering and obstructing antitumor immune responses. Front Immunol 11:940. https:\/\/doi.org\/10.3389\/fimmu.2020.00940","journal-title":"Front Immunol"},{"key":"1389_CR90","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41416-019-0531-5","volume":"121","author":"C Laheurte","year":"2019","unstructured":"Laheurte C, Dosset M, Vernerey D, Boullerot L, Gaugler B, Gravelin E, Kaulek V, Jacquin M, Cuche L, Eberst G, Jacoulet P, Fabre E, Le Pimpec-Barthes F, Tartour E, De Carvalho BM, Westeel V, Adot\u00e9vi O (2019) Distinct prognostic value of circulating anti-telomerase CD4(+) Th1 immunity and exhausted PD-1(+)\/TIM-3(+) T cells in lung cancer. Br J Cancer 121:405\u2013416. https:\/\/doi.org\/10.1038\/s41416-019-0531-5","journal-title":"Br J Cancer"},{"key":"1389_CR91","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/83130","volume":"2","author":"LL Lanier","year":"2001","unstructured":"Lanier LL (2001) On guard\u2014activating NK cell receptors. Nat Immunol 2:23\u201327. https:\/\/doi.org\/10.1038\/83130","journal-title":"Nat Immunol"},{"key":"1389_CR92","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s0952-7915(00)00218-1","volume":"13","author":"A Lanzavecchia","year":"2001","unstructured":"Lanzavecchia A, Sallusto F (2001) The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 13:291\u2013298. https:\/\/doi.org\/10.1016\/s0952-7915(00)00218-1","journal-title":"Curr Opin Immunol"},{"key":"1389_CR93","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1387\/ijdb.113371dl","volume":"55","author":"D Laoui","year":"2011","unstructured":"Laoui D, Movahedi K, Van Overmeire E, Van Den Bossche J, Schouppe E, Mommer C, Nikolaou A, Morias Y, De Baetselier P, Van Ginderachter JA (2011) Tumor-associated macrophages in breast cancer: distinct subsets, distinct functions. Int J Dev Biol 55:861\u2013867. https:\/\/doi.org\/10.1387\/ijdb.113371dl","journal-title":"Int J Dev Biol"},{"key":"1389_CR94","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.4049\/jimmunol.165.4.1847","volume":"165","author":"BR Lauwerys","year":"2000","unstructured":"Lauwerys BR, Garot N, Renauld JC, Houssiau FA (2000) Cytokine production and killer activity of NK\/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18. J Immunol 165:1847\u20131853. https:\/\/doi.org\/10.4049\/jimmunol.165.4.1847","journal-title":"J Immunol"},{"key":"1389_CR95","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1016\/j.celrep.2016.11.062","volume":"17","author":"CR Lee","year":"2016","unstructured":"Lee CR, Kwak Y, Yang T, Han JH, Park SH, Ye MB, Lee W, Sim KY, Kang JA, Kim YC, Mazmanian SK, Park SG (2016) Myeloid-derived suppressor cells are controlled by regulatory T cells via TGF-beta during murine colitis. Cell Rep 17:3219\u20133232. https:\/\/doi.org\/10.1016\/j.celrep.2016.11.062","journal-title":"Cell Rep"},{"key":"1389_CR96","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/s1074-7613(00)80441-0","volume":"6","author":"PJ Leibson","year":"1997","unstructured":"Leibson PJ (1997) Signal transduction during natural killer cell activation: inside the mind of a killer. Immunity 6:655\u2013661. https:\/\/doi.org\/10.1016\/s1074-7613(00)80441-0","journal-title":"Immunity"},{"key":"1389_CR97","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1158\/0008-5472.CAN-05-4005","volume":"66","author":"CE Lewis","year":"2006","unstructured":"Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66:605\u2013612. https:\/\/doi.org\/10.1158\/0008-5472.CAN-05-4005","journal-title":"Cancer Res"},{"key":"1389_CR98","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4049\/jimmunol.182.1.240","volume":"182","author":"H Li","year":"2009","unstructured":"Li H, Han Y, Guo Q, Zhang M, Cao X (2009a) Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J Immunol 182:240\u2013249. https:\/\/doi.org\/10.4049\/jimmunol.182.1.240","journal-title":"J Immunol"},{"key":"1389_CR99","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.4049\/jimmunol.0803773","volume":"183","author":"Q Li","year":"2009","unstructured":"Li Q, Teitz-Tennenbaum S, Donald EJ, Li M, Chang AE (2009b) In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy. J Immunol 183:3195\u20133203. https:\/\/doi.org\/10.4049\/jimmunol.0803773","journal-title":"J Immunol"},{"key":"1389_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.738373","volume":"9","author":"X Li","year":"2021","unstructured":"Li X, Yang Y, Huang Q, Deng Y, Guo F, Wang G, Liu M (2021) Crosstalk between the tumor microenvironment and cancer cells: a promising predictive biomarker for immune checkpoint inhibitors. Front Cell Dev Biol 9:738373. https:\/\/doi.org\/10.3389\/fcell.2021.738373","journal-title":"Front Cell Dev Biol"},{"key":"1389_CR101","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/1471-2407-9-192","volume":"9","author":"C Lin","year":"2009","unstructured":"Lin C, Chien SY, Chen LS, Kuo SJ, Chang TW, Chen DR (2009) Triple negative breast carcinoma is a prognostic factor in Taiwanese women. BMC Cancer 9:192. https:\/\/doi.org\/10.1186\/1471-2407-9-192","journal-title":"BMC Cancer"},{"key":"1389_CR102","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1158\/0008-5472.Can-12-3450","volume":"73","author":"S Lindner","year":"2013","unstructured":"Lindner S, Dahlke K, Sontheimer K, Hagn M, Kaltenmeier C, Barth TF, Beyer T, Reister F, Fabricius D, Lotfi R, Lunov O, Nienhaus GU, Simmet T, Kreienberg R, M\u00f6ller P, Schrezenmeier H, Jahrsd\u00f6rfer B (2013) Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res 73:2468\u20132479. https:\/\/doi.org\/10.1158\/0008-5472.Can-12-3450","journal-title":"Cancer Res"},{"key":"1389_CR103","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/cjp2.31","volume":"2","author":"A Ling","year":"2016","unstructured":"Ling A, Lundberg IV, Ekl\u00f6f V, Wikberg ML, \u00d8berg \u00c7, Edin S, Palmqvist R (2016) The infiltration, and prognostic importance, of Th1 lymphocytes vary in molecular subgroups of colorectal cancer. J Pathol Clin Res 2:21\u201331. https:\/\/doi.org\/10.1002\/cjp2.31","journal-title":"J Pathol Clin Res"},{"key":"1389_CR104","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.4049\/jimmunol.169.5.2756","volume":"169","author":"UK Liyanage","year":"2002","unstructured":"Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169:2756\u20132761. https:\/\/doi.org\/10.4049\/jimmunol.169.5.2756","journal-title":"J Immunol"},{"key":"1389_CR105","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12865-020-0337-5","volume":"21","author":"AJ Luker","year":"2020","unstructured":"Luker AJ, Graham LJ, Smith TM Jr, Camarena C, Zellner MP, Gilmer JS, Damle SR, Conrad DH, Bear HD, Martin RK (2020) The DNA methyltransferase inhibitor, guadecitabine, targets tumor-induced myelopoiesis and recovers T cell activity to slow tumor growth in combination with adoptive immunotherapy in a mouse model of breast cancer. BMC Immunol 21:8. https:\/\/doi.org\/10.1186\/s12865-020-0337-5","journal-title":"BMC Immunol"},{"key":"1389_CR106","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/jlb.63.4.418","volume":"63","author":"MF Mackey","year":"1998","unstructured":"Mackey MF, Barth RJ Jr, Noelle RJ (1998) The role of CD40\/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J Leukoc Biol 63:418\u2013428. https:\/\/doi.org\/10.1002\/jlb.63.4.418","journal-title":"J Leukoc Biol"},{"key":"1389_CR107","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-91311-3","volume-title":"Interaction of immune and cancer cells","author":"K Magdalena","year":"2016","unstructured":"Magdalena K (2016) Interaction of immune and cancer cells. Springer, Cham.\u00a0https:\/\/doi.org\/10.1007\/978-3-030-91311-3","edition":"2"},{"key":"1389_CR108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.csbj.2018.11.004","volume":"17","author":"NR Maimela","year":"2019","unstructured":"Maimela NR, Liu S, Zhang Y (2019) Fates of CD8+ T cells in tumor microenvironment. Comput Struct Biotechnol J 17:1\u201313. https:\/\/doi.org\/10.1016\/j.csbj.2018.11.004","journal-title":"Comput Struct Biotechnol J"},{"key":"1389_CR109","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani A, Marchesi F, Malesci A, Laghi L, Allavena P (2017) Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol 14:399\u2013416. https:\/\/doi.org\/10.1038\/nrclinonc.2016.217","journal-title":"Nat Rev Clin Oncol"},{"key":"1389_CR110","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1158\/0008-5472.CAN-12-4115","volume":"73","author":"Y Mao","year":"2013","unstructured":"Mao Y, Poschke I, Wennerberg E, Pico De Coana Y, Egyhazi Brage S, Schultz I, Hansson J, Masucci G, Lundqvist A, Kiessling R (2013) Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms. Cancer Res 73:3877\u20133887. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-4115","journal-title":"Cancer Res"},{"key":"1389_CR111","doi-asserted-by":"publisher","first-page":"20130676","DOI":"10.1259\/bjr.20130676","volume":"87","author":"SR Mckeown","year":"2014","unstructured":"Mckeown SR (2014) Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br J Radiol 87:20130676. https:\/\/doi.org\/10.1259\/bjr.20130676","journal-title":"Br J Radiol"},{"key":"1389_CR112","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.bbadis.2015.10.015","volume":"1862","author":"C Melero-Jerez","year":"2016","unstructured":"Melero-Jerez C, Ortega MC, Moline-Velazquez V, Clemente D (2016) Myeloid derived suppressor cells in inflammatory conditions of the central nervous system. Biochim Biophys Acta 1862:368\u2013380. https:\/\/doi.org\/10.1016\/j.bbadis.2015.10.015","journal-title":"Biochim Biophys Acta"},{"key":"1389_CR113","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1158\/0008-5472.CAN-15-1737","volume":"76","author":"CD Mills","year":"2016","unstructured":"Mills CD, Lenz LL, Harris RA (2016) A breakthrough: macrophage-directed cancer immunotherapy. Cancer Res 76:513\u2013516. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1737","journal-title":"Cancer Res"},{"key":"1389_CR114","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1084\/jem.20101956","volume":"208","author":"B Molon","year":"2011","unstructured":"Molon B, Ugel S, Del Pozzo F, Soldani C, Zilio S, Avella D, De Palma A, Mauri P, Monegal A, Rescigno M, Savino B, Colombo P, Jonjic N, Pecanic S, Lazzarato L, Fruttero R, Gasco A, Bronte V, Viola A (2011) Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. J Exp Med 208:1949\u20131962. https:\/\/doi.org\/10.1084\/jem.20101956","journal-title":"J Exp Med"},{"key":"1389_CR115","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/nri3064","volume":"11","author":"GT Motz","year":"2011","unstructured":"Motz GT, Coukos G (2011) The parallel lives of angiogenesis and immunosuppression: cancer and other tales. Nat Rev Immunol 11:702\u2013711. https:\/\/doi.org\/10.1038\/nri3064","journal-title":"Nat Rev Immunol"},{"key":"1389_CR116","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/35065016","volume":"410","author":"A Muller","year":"2001","unstructured":"Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, Mcclanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50\u201356. https:\/\/doi.org\/10.1038\/35065016","journal-title":"Nature"},{"key":"1389_CR117","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1126\/science.aaw7875","volume":"365","author":"LL Munn","year":"2019","unstructured":"Munn LL, Jain RK (2019) Vascular regulation of antitumor immunity. Science 365:544\u2013545. https:\/\/doi.org\/10.1126\/science.aaw7875","journal-title":"Science"},{"key":"1389_CR118","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nrc2444","volume":"8","author":"C Murdoch","year":"2008","unstructured":"Murdoch C, Muthana M, Coffelt SB, Lewis CE (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8:618\u2013631. https:\/\/doi.org\/10.1038\/nrc2444","journal-title":"Nat Rev Cancer"},{"key":"1389_CR119","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4049\/jimmunol.1300654","volume":"191","author":"S Nagaraj","year":"2013","unstructured":"Nagaraj S, Youn JI, Gabrilovich DI (2013) Reciprocal relationship between myeloid-derived suppressor cells and T cells. J Immunol 191:17\u201323. https:\/\/doi.org\/10.4049\/jimmunol.1300654","journal-title":"J Immunol"},{"key":"1389_CR120","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","volume":"211","author":"MZ Noman","year":"2014","unstructured":"Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, Bronte V, Chouaib S (2014) PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med 211:781\u2013790. https:\/\/doi.org\/10.1084\/jem.20131916","journal-title":"J Exp Med"},{"key":"1389_CR121","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1158\/0008-5472.Can-04-3232","volume":"65","author":"LA Ormandy","year":"2005","unstructured":"Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F (2005) Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 65:2457\u20132464. https:\/\/doi.org\/10.1158\/0008-5472.Can-04-3232","journal-title":"Cancer Res"},{"key":"1389_CR122","doi-asserted-by":"publisher","first-page":"40","DOI":"10.12703\/P5-40","volume":"5","author":"TA Packard","year":"2013","unstructured":"Packard TA, Cambier JC (2013) B lymphocyte antigen receptor signaling: initiation, amplification, and regulation. F1000Prime Rep 5:40. https:\/\/doi.org\/10.12703\/P5-40","journal-title":"F1000Prime Rep"},{"key":"1389_CR123","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","volume":"577","author":"F Petitprez","year":"2020","unstructured":"Petitprez F, De Reyni\u00e8s A, Keung EZ, Chen TW-W, Sun C-M, Calderaro J, Jeng Y-M, Hsiao L-P, Lacroix L, Bougo\u00fcin A, Moreira M, Lacroix G, Natario I, Adam J, Lucchesi C, Laizet YH, Toulmonde M, Burgess MA, Bolejack V, Reinke D, Wani KM, Wang W-L, Lazar AJ, Roland CL, Wargo JA, Italiano A, Saut\u00e8s-Fridman C, Tawbi HA, Fridman WH (2020) B cells are associated with survival and immunotherapy response in sarcoma. Nature 577:556\u2013560. https:\/\/doi.org\/10.1038\/s41586-019-1906-8","journal-title":"Nature"},{"key":"1389_CR124","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12967-020-02667-4","volume":"19","author":"V Pietrobon","year":"2021","unstructured":"Pietrobon V, Marincola FM (2021) Hypoxia and the phenomenon of immune exclusion. J Transl Med 19:9. https:\/\/doi.org\/10.1186\/s12967-020-02667-4","journal-title":"J Transl Med"},{"key":"1389_CR125","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1182\/blood-2005-07-2965","volume":"107","author":"B Piqueras","year":"2006","unstructured":"Piqueras B, Connolly J, Freitas H, Palucka AK, Banchereau J (2006) Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood 107:2613\u20132618. https:\/\/doi.org\/10.1182\/blood-2005-07-2965","journal-title":"Blood"},{"key":"1389_CR126","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141:39\u201351. https:\/\/doi.org\/10.1016\/j.cell.2010.03.014","journal-title":"Cell"},{"key":"1389_CR127","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1084\/jem.20170277","volume":"216","author":"M Rapp","year":"2019","unstructured":"Rapp M, Wintergerst MWM, Kunz WG, Vetter VK, Knott MML, Lisowski D, Haubner S, Moder S, Thaler R, Eiber S, Meyer B, R\u00f6hrle N, Piseddu I, Grassmann S, Layritz P, K\u00fchnemuth B, Stutte S, Bourquin C, Von Andrian UH, Endres S, Anz D (2019) CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes. J Exp Med 216:1170\u20131181. https:\/\/doi.org\/10.1084\/jem.20170277","journal-title":"J Exp Med"},{"key":"1389_CR128","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.it.2015.02.005","volume":"36","author":"LB Rivera","year":"2015","unstructured":"Rivera LB, Bergers G (2015) Intertwined regulation of angiogenesis and immunity by myeloid cells. Trends Immunol 36:240\u2013249. https:\/\/doi.org\/10.1016\/j.it.2015.02.005","journal-title":"Trends Immunol"},{"key":"1389_CR129","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1158\/0008-5472.Can-05-2429","volume":"66","author":"JM Roda","year":"2006","unstructured":"Roda JM, Parihar R, Magro C, Nuovo GJ, Tridandapani S, Carson WE 3rd (2006) Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells. Cancer Res 66:517\u2013526. https:\/\/doi.org\/10.1158\/0008-5472.Can-05-2429","journal-title":"Cancer Res"},{"key":"1389_CR130","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ccr.2010.11.009","volume":"19","author":"C Rolny","year":"2011","unstructured":"Rolny C, Mazzone M, Tugues S, Laoui D, Johansson I, Coulon C, Squadrito ML, Segura I, Li X, Knevels E, Costa S, Vinckier S, Dresselaer T, Akerud P, De Mol M, Salomaki H, Phillipson M, Wyns S, Larsson E, Buysschaert I, Botling J, Himmelreich U, Van Ginderachter JA, De Palma M, Dewerchin M, Claesson-Welsh L, Carmeliet P (2011) HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell 19:31\u201344. https:\/\/doi.org\/10.1016\/j.ccr.2010.11.009","journal-title":"Cancer Cell"},{"key":"1389_CR131","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00043","author":"M Romano","year":"2019","unstructured":"Romano M, Fanelli G, Albany CJ, Giganti G, Lombardi G (2019) Past, present, and future of regulatory T cell therapy in transplantation and autoimmunity. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.00043","journal-title":"Front Immunol"},{"key":"1389_CR132","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00216","author":"CM Rueda","year":"2016","unstructured":"Rueda CM, Jackson CM, Chougnet CA (2016) Regulatory T-cell-mediated suppression of conventional T-cells and dendritic cells by different cAMP intracellular pathways. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2016.00216","journal-title":"Front Immunol"},{"key":"1389_CR133","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.ccell.2015.02.015","volume":"27","author":"B Ruffell","year":"2015","unstructured":"Ruffell B, Coussens LM (2015) Macrophages and therapeutic resistance in cancer. Cancer Cell 27:462\u2013472. https:\/\/doi.org\/10.1016\/j.ccell.2015.02.015","journal-title":"Cancer Cell"},{"key":"1389_CR134","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1002\/jcp.26075","volume":"233","author":"E Safarzadeh","year":"2018","unstructured":"Safarzadeh E, Orangi M, Mohammadi H, Babaie F, Baradaran B (2018) Myeloid-derived suppressor cells: important contributors to tumor progression and metastasis. J Cell Physiol 233:3024\u20133036. https:\/\/doi.org\/10.1002\/jcp.26075","journal-title":"J Cell Physiol"},{"key":"1389_CR135","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1158\/2159-8290.Cd-15-0510","volume":"6","author":"AR S\u00e1nchez-Paulete","year":"2016","unstructured":"S\u00e1nchez-Paulete AR, Cueto FJ, Mart\u00ednez-L\u00f3pez M, Labiano S, Morales-Kastresana A, Rodr\u00edguez-Ruiz ME, Jure-Kunkel M, Azpilikueta A, Aznar MA, Quetglas JI, Sancho D, Melero I (2016) Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells. Cancer Discov 6:71\u201379. https:\/\/doi.org\/10.1158\/2159-8290.Cd-15-0510","journal-title":"Cancer Discov"},{"key":"1389_CR136","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1056\/NEJMoa061884","volume":"355","author":"A Sandler","year":"2006","unstructured":"Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH (2006) Paclitaxel\u2013carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 355:2542\u20132550. https:\/\/doi.org\/10.1056\/NEJMoa061884","journal-title":"N Engl J Med"},{"key":"1389_CR137","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064835","volume":"8","author":"S Sarkar","year":"2013","unstructured":"Sarkar S, Germeraad WT, Rouschop KM, Steeghs EM, Van Gelder M, Bos GM, Wieten L (2013) Hypoxia induced impairment of NK cell cytotoxicity against multiple myeloma can be overcome by IL-2 activation of the NK cells. PLoS ONE 8:e64835. https:\/\/doi.org\/10.1371\/journal.pone.0064835","journal-title":"PLoS ONE"},{"key":"1389_CR138","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/cmi.2017.35","volume":"14","author":"A Sarvaria","year":"2017","unstructured":"Sarvaria A, Madrigal JA, Saudemont A (2017) B cell regulation in cancer and anti-tumor immunity. Cell Mol Immunol 14:662\u2013674. https:\/\/doi.org\/10.1038\/cmi.2017.35","journal-title":"Cell Mol Immunol"},{"key":"1389_CR139","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1002\/cncr.11618","volume":"98","author":"T Sasada","year":"2003","unstructured":"Sasada T, Kimura M, Yoshida Y, Kanai M, Takabayashi A (2003) CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98:1089\u20131099. https:\/\/doi.org\/10.1002\/cncr.11618","journal-title":"Cancer"},{"key":"1389_CR140","doi-asserted-by":"publisher","first-page":"18538","DOI":"10.1073\/pnas.0509182102","volume":"102","author":"E Sato","year":"2005","unstructured":"Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, Kepner J, Odunsi T, Ritter G, Lele S, Chen YT, Ohtani H, Old LJ, Odunsi K (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+\/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102:18538\u201318543. https:\/\/doi.org\/10.1073\/pnas.0509182102","journal-title":"Proc Natl Acad Sci USA"},{"key":"1389_CR141","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.trecan.2016.10.016","volume":"2","author":"L Schito","year":"2016","unstructured":"Schito L, Semenza GL (2016) Hypoxia-inducible factors: master regulators of cancer progression. Trends Cancer 2:758\u2013770. https:\/\/doi.org\/10.1016\/j.trecan.2016.10.016","journal-title":"Trends Cancer"},{"key":"1389_CR142","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1182\/blood-2011-03-343293","volume":"118","author":"A Scholz","year":"2011","unstructured":"Scholz A, Lang V, Henschler R, Czabanka M, Vajkoczy P, Chavakis E, Drynski J, Harter PN, Mittelbronn M, Dumont DJ, Plate KH, Reiss Y (2011) Angiopoietin-2 promotes myeloid cell infiltration in a beta(2)-integrin-dependent manner. Blood 118:5050\u20135059. https:\/\/doi.org\/10.1182\/blood-2011-03-343293","journal-title":"Blood"},{"key":"1389_CR143","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40425-016-0145-x","volume":"4","author":"M Schwartz","year":"2016","unstructured":"Schwartz M, Zhang Y, Rosenblatt JD (2016) B cell regulation of the anti-tumor response and role in carcinogenesis. J Immunother Cancer 4:40. https:\/\/doi.org\/10.1186\/s40425-016-0145-x","journal-title":"J Immunother Cancer"},{"key":"1389_CR144","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1146\/annurev-pathol-012513-104720","volume":"9","author":"GL Semenza","year":"2014","unstructured":"Semenza GL (2014) Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology. Annu Rev Pathol 9:47\u201371. https:\/\/doi.org\/10.1146\/annurev-pathol-012513-104720","journal-title":"Annu Rev Pathol"},{"key":"1389_CR145","unstructured":"Shacter E, Weitzman SA (2002) Chronic inflammation and cancer. Oncology (Williston Park) 16:217\u2013226, 229; discussion 230\u2013212"},{"key":"1389_CR146","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/hepr.12167","volume":"44","author":"P Shen","year":"2014","unstructured":"Shen P, Wang A, He M, Wang Q, Zheng S (2014) Increased circulating Lin(\u2212\/low) CD33(+) HLA-DR(\u2212) myeloid-derived suppressor cells in hepatocellular carcinoma patients. Hepatol Res 44:639\u2013650. https:\/\/doi.org\/10.1111\/hepr.12167","journal-title":"Hepatol Res"},{"key":"1389_CR147","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1365-2141.2008.07340.x","volume":"143","author":"J Shi","year":"2008","unstructured":"Shi J, Tricot G, Szmania S, Rosen N, Garg TK, Malaviarachchi PA, Moreno A, Dupont B, Hsu KC, Baxter-Lowe LA, Cottler-Fox M, Shaughnessy JD Jr, Barlogie B, Van Rhee F (2008) Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation. Br J Haematol 143:641\u2013653. https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07340.x","journal-title":"Br J Haematol"},{"key":"1389_CR148","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1007\/s00018-016-2278-y","volume":"73","author":"C Shipp","year":"2016","unstructured":"Shipp C, Speigl L, Janssen N, Martens A, Pawelec G (2016) A clinical and biological perspective of human myeloid-derived suppressor cells in cancer. Cell Mol Life Sci 73:4043\u20134061. https:\/\/doi.org\/10.1007\/s00018-016-2278-y","journal-title":"Cell Mol Life Sci"},{"key":"1389_CR149","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/mi.2017.8","volume":"10","author":"D Sichien","year":"2017","unstructured":"Sichien D, Lambrecht BN, Guilliams M, Scott CL (2017) Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissues. Mucosal Immunol 10:831\u2013844. https:\/\/doi.org\/10.1038\/mi.2017.8","journal-title":"Mucosal Immunol"},{"key":"1389_CR150","doi-asserted-by":"publisher","first-page":"977","DOI":"10.4049\/jimmunol.179.2.977","volume":"179","author":"P Sinha","year":"2007","unstructured":"Sinha P, Clements VK, Bunt SK, Albelda SM, Ostrand-Rosenberg S (2007) Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. J Immunol 179:977\u2013983. https:\/\/doi.org\/10.4049\/jimmunol.179.2.977","journal-title":"J Immunol"},{"key":"1389_CR151","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","volume":"31","author":"S Spranger","year":"2017","unstructured":"Spranger S, Dai D, Horton B, Gajewski TF (2017) Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy. Cancer Cell 31:711-723.e714. https:\/\/doi.org\/10.1016\/j.ccell.2017.04.003","journal-title":"Cancer Cell"},{"key":"1389_CR152","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1158\/0008-5472.CAN-09-2587","volume":"70","author":"MK Srivastava","year":"2010","unstructured":"Srivastava MK, Sinha P, Clements VK, Rodriguez P, Ostrand-Rosenberg S (2010) Myeloid-derived suppressor cells inhibit T-cell activation by depleting cysteine and cysteine. Cancer Res 70:68\u201377. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-2587","journal-title":"Cancer Res"},{"key":"1389_CR153","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.tcb.2020.06.003","volume":"30","author":"M St Paul","year":"2020","unstructured":"St Paul M, Ohashi PS (2020) The roles of CD8(+) T cell subsets in antitumor immunity. Trends Cell Biol 30:695\u2013704. https:\/\/doi.org\/10.1016\/j.tcb.2020.06.003","journal-title":"Trends Cell Biol"},{"key":"1389_CR154","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fonc.2014.00069","volume":"4","author":"C Stockmann","year":"2014","unstructured":"Stockmann C, Schadendorf D, Klose R, Helfrich I (2014) The impact of the immune system on tumor: angiogenesis and vascular remodeling. Front Oncol 4:69. https:\/\/doi.org\/10.3389\/fonc.2014.00069","journal-title":"Front Oncol"},{"key":"1389_CR155","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/j.celrep.2019.12.081","volume":"30","author":"JA Sullivan","year":"2020","unstructured":"Sullivan JA, Tomita Y, Jankowska-Gan E, Lema DA, Arvedson MP, Nair A, Bracamonte-Baran W, Zhou Y, Meyer KK, Zhong W, Sawant DV, Szymczak-Workman AL, Zhang Q, Workman CJ, Hong S, DaA V, Burlingham WJ (2020) Treg-cell-derived IL-35-coated extracellular vesicles promote infectious tolerance. Cell Rep 30:1039-1051.e1035. https:\/\/doi.org\/10.1016\/j.celrep.2019.12.081","journal-title":"Cell Rep"},{"key":"1389_CR156","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1615\/critrevoncog.2014010805","volume":"19","author":"CM Sungur","year":"2014","unstructured":"Sungur CM, Murphy WJ (2014) Positive and negative regulation by NK cells in cancer. Crit Rev Oncog 19:57\u201366. https:\/\/doi.org\/10.1615\/critrevoncog.2014010805","journal-title":"Crit Rev Oncog"},{"key":"1389_CR157","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1365-2796.2009.02121.x","volume":"266","author":"T Sutlu","year":"2009","unstructured":"Sutlu T, Alici E (2009) Natural killer cell-based immunotherapy in cancer: current insights and future prospects. J Intern Med 266:154\u2013181. https:\/\/doi.org\/10.1111\/j.1365-2796.2009.02121.x","journal-title":"J Intern Med"},{"key":"1389_CR158","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/eji.201444625","volume":"45","author":"H Tao","year":"2015","unstructured":"Tao H, Lu L, Xia Y, Dai F, Wang Y, Bao Y, Lundy SK, Ito F, Pan Q, Zhang X, Zheng F, Shu G, Fang B, Jiang J, Xia J, Huang S, Li Q, Chang AE (2015) Antitumor effector B cells directly kill tumor cells via the Fas\/FasL pathway and are regulated by IL-10. Eur J Immunol 45:999\u20131009. https:\/\/doi.org\/10.1002\/eji.201444625","journal-title":"Eur J Immunol"},{"key":"1389_CR159","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41417-020-0183-x","volume":"28","author":"RE Tay","year":"2021","unstructured":"Tay RE, Richardson EK, Toh HC (2021) Revisiting the role of CD4(+) T cells in cancer immunotherapy\u2014new insights into old paradigms. Cancer Gene Ther 28:5\u201317. https:\/\/doi.org\/10.1038\/s41417-020-0183-x","journal-title":"Cancer Gene Ther"},{"key":"1389_CR160","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1056\/NEJMoa1309748","volume":"370","author":"KS Tewari","year":"2014","unstructured":"Tewari KS, Sill MW, Long HJ 3rd, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, Monk BJ (2014) Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 370:734\u2013743. https:\/\/doi.org\/10.1056\/NEJMoa1309748","journal-title":"N Engl J Med"},{"key":"1389_CR161","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nature21724","volume":"544","author":"L Tian","year":"2017","unstructured":"Tian L, Goldstein A, Wang H, Ching Lo H, Sun Kim I, Welte T, Sheng K, Dobrolecki LE, Zhang X, Putluri N, Phung TL, Mani SA, Stossi F, Sreekumar A, Mancini MA, Decker WK, Zong C, Lewis MT, Zhang XH (2017) Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming. Nature 544:250\u2013254. https:\/\/doi.org\/10.1038\/nature21724","journal-title":"Nature"},{"key":"1389_CR162","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G (2003) Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3:133\u2013146. https:\/\/doi.org\/10.1038\/nri1001","journal-title":"Nat Rev Immunol"},{"key":"1389_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/cells8121647","author":"EK Vetsika","year":"2019","unstructured":"Vetsika EK, Koukos A, Kotsakis A (2019) Myeloid-derived suppressor cells: major figures that shape the immunosuppressive and angiogenic network in cancer. Cells. https:\/\/doi.org\/10.3390\/cells8121647","journal-title":"Cells"},{"key":"1389_CR164","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1084\/jem.20140559","volume":"212","author":"T Voron","year":"2015","unstructured":"Voron T, Colussi O, Marcheteau E, Pernot S, Nizard M, Pointet AL, Latreche S, Bergaya S, Benhamouda N, Tanchot C, Stockmann C, Combe P, Berger A, Zinzindohoue F, Yagita H, Tartour E, Taieb J, Terme M (2015) VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors. J Exp Med 212:139\u2013148. https:\/\/doi.org\/10.1084\/jem.20140559","journal-title":"J Exp Med"},{"key":"1389_CR165","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1002\/hep.27867","volume":"62","author":"S Wan","year":"2015","unstructured":"Wan S, Kuo N, Kryczek I, Zou W, Welling TH (2015) Myeloid cells in hepatocellular carcinoma. Hepatology 62:1304\u20131312. https:\/\/doi.org\/10.1002\/hep.27867","journal-title":"Hepatology"},{"key":"1389_CR166","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1002\/cam4.2327","volume":"8","author":"J Wang","year":"2019","unstructured":"Wang J, Li D, Cang H, Guo B (2019) Crosstalk between cancer and immune cells: role of tumor-associated macrophages in the tumor microenvironment. Cancer Med 8:4709\u20134721. https:\/\/doi.org\/10.1002\/cam4.2327","journal-title":"Cancer Med"},{"key":"1389_CR167","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.4049\/jimmunol.178.3.1357","volume":"178","author":"SK Watkins","year":"2007","unstructured":"Watkins SK, Egilmez NK, Suttles J, Stout RD (2007) IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo. J Immunol 178:1357\u20131362. https:\/\/doi.org\/10.4049\/jimmunol.178.3.1357","journal-title":"J Immunol"},{"key":"1389_CR168","doi-asserted-by":"publisher","first-page":"35490","DOI":"10.18632\/oncotarget.8204","volume":"7","author":"L Wen","year":"2016","unstructured":"Wen L, Gong P, Liang C, Shou D, Liu B, Chen Y, Bao C, Chen L, Liu X, Liang T, Gong W (2016) Interplay between myeloid-derived suppressor cells (MDSCs) and Th17 cells: foe or friend? Oncotarget 7:35490\u201335496. https:\/\/doi.org\/10.18632\/oncotarget.8204","journal-title":"Oncotarget"},{"key":"1389_CR169","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27:5904\u20135912. https:\/\/doi.org\/10.1038\/onc.2008.271","journal-title":"Oncogene"},{"key":"1389_CR170","first-page":"606","volume":"9","author":"AM Wolf","year":"2003","unstructured":"Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B (2003) Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 9:606\u2013612","journal-title":"Clin Cancer Res"},{"key":"1389_CR171","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1158\/1078-0432.Ccr-18-1481","volume":"24","author":"MCA Wouters","year":"2018","unstructured":"Wouters MCA, Nelson BH (2018) Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer. Clin Cancer Res 24:6125\u20136135. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-1481","journal-title":"Clin Cancer Res"},{"key":"1389_CR172","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.2147\/OTT.S158206","volume":"11","author":"Y Xia","year":"2018","unstructured":"Xia Y, Jiang L, Zhong T (2018) The role of HIF-1alpha in chemo-\/radioresistant tumors. OncoTargets Ther 11:3003\u20133011. https:\/\/doi.org\/10.2147\/OTT.S158206","journal-title":"OncoTargets Ther"},{"key":"1389_CR173","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s00005-020-00601-6","volume":"68","author":"Y Yan","year":"2020","unstructured":"Yan Y, Zhang L, Zuo Y, Qian H, Liu C (2020) Immune checkpoint blockade in cancer immunotherapy: mechanisms, clinical outcomes, and safety profiles of PD-1\/PD-L1 inhibitors. Arch Immunol Ther Exp (WArsz) 68:36. https:\/\/doi.org\/10.1007\/s00005-020-00601-6","journal-title":"Arch Immunol Ther Exp (WArsz)"},{"key":"1389_CR174","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064159","volume":"8","author":"C Yang","year":"2013","unstructured":"Yang C, Lee H, Pal S, Jove V, Deng J, Zhang W, Hoon DS, Wakabayashi M, Forman S, Yu H (2013) B cells promote tumor progression via STAT3 regulated-angiogenesis. PLoS ONE 8:e64159. https:\/\/doi.org\/10.1371\/journal.pone.0064159","journal-title":"PLoS ONE"},{"key":"1389_CR175","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1038\/s41416-021-01310-3","volume":"124","author":"W Ye","year":"2021","unstructured":"Ye W, Olsson-Brown A, Watson RA, Cheung VTF, Morgan RD, Nassiri I, Cooper R, Taylor CA, Akbani U, Brain O, Matin RN, Coupe N, Middleton MR, Coles M, Sacco JJ, Payne MJ, Fairfax BP (2021) Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles. Br J Cancer 124:1661\u20131669. https:\/\/doi.org\/10.1038\/s41416-021-01310-3","journal-title":"Br J Cancer"},{"key":"1389_CR176","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jhep.2014.10.029","volume":"62","author":"OW Yeung","year":"2015","unstructured":"Yeung OW, Lo CM, Ling CC, Qi X, Geng W, Li CX, Ng KT, Forbes SJ, Guan XY, Poon RT, Fan ST, Man K (2015) Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. J Hepatol 62:607\u2013616. https:\/\/doi.org\/10.1016\/j.jhep.2014.10.029","journal-title":"J Hepatol"},{"key":"1389_CR177","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","volume":"181","author":"JI Youn","year":"2008","unstructured":"Youn JI, Nagaraj S, Collazo M, Gabrilovich DI (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J Immunol 181:5791\u20135802. https:\/\/doi.org\/10.4049\/jimmunol.181.8.5791","journal-title":"J Immunol"},{"key":"1389_CR178","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s0192-0561(99)00008-9","volume":"21","author":"MR Young","year":"1999","unstructured":"Young MR, Lathers DM (1999) Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers. Int J Immunopharmacol 21:241\u2013252. https:\/\/doi.org\/10.1016\/s0192-0561(99)00008-9","journal-title":"Int J Immunopharmacol"},{"key":"1389_CR179","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.trecan.2016.10.010","volume":"2","author":"GJ Yuen","year":"2016","unstructured":"Yuen GJ, Demissie E, Pillai S (2016) B lymphocytes and cancer: a love\u2013hate relationship. Trends Cancer 2:747\u2013757. https:\/\/doi.org\/10.1016\/j.trecan.2016.10.010","journal-title":"Trends Cancer"},{"key":"1389_CR180","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang L, Yu X, Zheng L, Zhang Y, Li Y, Fang Q, Gao R, Kang B, Zhang Q, Huang JY, Konno H, Guo X, Ye Y, Gao S, Wang S, Hu X, Ren X, Shen Z, Ouyang W, Zhang Z (2018) Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564:268\u2013272. https:\/\/doi.org\/10.1038\/s41586-018-0694-x","journal-title":"Nature"},{"key":"1389_CR181","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, Modak M, Carotta S, Haslinger C, Kind D, Peet GW, Zhong G, Lu S, Zhu W, Mao Y, Xiao M, Bergmann M, Hu X, Kerkar SP, Vogt AB, Pflanz S, Liu K, Peng J, Ren X, Zhang Z (2019) Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell 179:829-845.e820. https:\/\/doi.org\/10.1016\/j.cell.2019.10.003","journal-title":"Cell"},{"key":"1389_CR182","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050946","volume":"7","author":"QW Zhang","year":"2012","unstructured":"Zhang QW, Liu L, Gong CY, Shi HS, Zeng YH, Wang XZ, Zhao YW, Wei YQ (2012) Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS ONE 7:e50946. https:\/\/doi.org\/10.1371\/journal.pone.0050946","journal-title":"PLoS ONE"},{"key":"1389_CR183","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1053\/j.gastro.2016.02.040","volume":"150","author":"SL Zhou","year":"2016","unstructured":"Zhou SL, Zhou ZJ, Hu ZQ, Huang XW, Wang Z, Chen EB, Fan J, Cao Y, Dai Z, Zhou J (2016) Tumor-associated neutrophils recruit macrophages and T-regulatory cells to promote progression of hepatocellular carcinoma and resistance to sorafenib. Gastroenterology 150:1646-1658.e1617. https:\/\/doi.org\/10.1053\/j.gastro.2016.02.040","journal-title":"Gastroenterology"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-022-01389-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12272-022-01389-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-022-01389-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T05:35:31Z","timestamp":1656740131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12272-022-01389-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":183,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1007\/s12272-022-01389-z","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"27 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}